Reem Karmali, MD, MD
Rare Disease / Clinical Research
Northwestern University
CHICAGO, IL
PI on 6 trialsNPI: 1083860282
ℹ
Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.
Report missing dataRare diseases treated or studied
Based on trial PI assignments and publication topics.
- Indolent primary cutaneous B-cell lymphoma
- High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement
- Post-transplant lymphoproliferative disease
- Aggressive B-cell non-Hodgkin lymphoma
- Aggressive primary cutaneous B-cell lymphoma
- T-cell/histiocyte rich large B cell lymphoma
- Intravascular large B-cell lymphoma
- Aggressive primary cutaneous T-cell lymphoma
- Diffuse large B-cell lymphoma with chronic inflammation
- Indolent primary cutaneous T-cell lymphoma